Home > Insider Trading > Filing (0001073397-14-000025)

Filing Details

Accession Number:: 0001073397-14-000025
Form Type:: 4/A
Zero Holdings:: No
Publication Time:: 2014-12-23 15:33:49
Reporting Period:: 2014-12-03

Filing Date:: 2014-12-23
Accepted Time:: 2014-12-23 15:33:49
Original Submission Date:: 2014-12-22
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
883984	Icu Medical Inc	ICUI	Surgical & Medical Instruments & Apparatus (3841)	330022692

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1073397	A George Lopez	951 Calle Amanecer San Clemente CA 92673		Yes	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2014-12-03	17,500	$84.43	432,735	No	4	S	Direct
Common Stock	Disposition	2014-12-04	10,700	$84.58	422,035	No	4	S	Direct
Common Stock	Disposition	2014-12-04	7,800	$83.81	414,235	No	4	S	Direct
Common Stock	Disposition	2014-12-05	8,000	$84.12	406,235	No	4	S	Direct
Common Stock	Disposition	2014-12-08	3,800	$84.15	402,435	No	4	S	Direct
Common Stock	Disposition	2014-12-09	2,200	$83.12	400,235	No	4	S	Direct
Common Stock	Disposition	2014-12-03	17,500	$84.43	1,169,343	No	4	S	Indirect	by Partnership
Common Stock	Disposition	2014-12-04	10,601	$84.59	1,158,742	No	4	S	Indirect	by Partnership
Common Stock	Disposition	2014-12-04	7,899	$83.80	1,150,843	No	4	S	Indirect	by Partnership
Common Stock	Disposition	2014-12-05	8,000	$84.12	1,142,843	No	4	S	Indirect	by Partnership
Common Stock	Disposition	2014-12-08	3,807	$84.15	1,139,036	No	4	S	Indirect	by Partnership
Common Stock	Disposition	2014-12-09	30	$84.03	1,139,006	No	4	S	Indirect	by Partnership
Common Stock	Disposition	2014-12-09	16,570	$83.53	1,122,436	No	4	S	Indirect	by Partnership
Common Stock	Disposition	2014-12-10	3,644	$83.11	1,118,792	No	4	S	Indirect	by Partnership
Common Stock	Disposition	2014-12-10	600	$84.07	1,118,192	No	4	S	Indirect	by Partnership
Common Stock	Disposition	2014-12-11	1,728	$83.05	1,116,464	No	4	S	Indirect	by Partnership
Common Stock	Disposition	2014-12-11	28,609	$82.16	1,087,855	No	4	S	Indirect	by Partnership
Common Stock	Disposition	2014-12-12	1,012	$80.97	1,086,843	No	4	S	Indirect	by Partnership

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Indirect	by Partnership
No	4	S	Indirect	by Partnership
No	4	S	Indirect	by Partnership
No	4	S	Indirect	by Partnership
No	4	S	Indirect	by Partnership
No	4	S	Indirect	by Partnership
No	4	S	Indirect	by Partnership
No	4	S	Indirect	by Partnership
No	4	S	Indirect	by Partnership
No	4	S	Indirect	by Partnership
No	4	S	Indirect	by Partnership
No	4	S	Indirect	by Partnership

Footnotes

This does not report new sales of shares. This is to indicate a correction to the weighted average sale price.
The price recorded in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $84.30 to $84.685, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
The price recorded in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $84.29 to $84.91, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
The price recorded in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $83.26 to $84.24, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
The price recorded in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $84.00 to $84.35, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
This does not report new sales of shares. This is to indicate a correction to the transaction date.
The price recorded in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $83.00 to $83.39, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
The price recorded in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $84.305 to $84.70, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
The price recorded in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $84.36 to $84.90, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
The price recorded in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $83.26 to $84.26, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
The price recorded in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $84.00 to $84.34, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
The price recorded in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $84.02 to $84.36, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
The price recorded in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $83.00 to $83.98, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
The price recorded in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $83.00 to $84.00, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
The price recorded in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $84.005 to $84.17, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
The price recorded in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $83.01 to $83.12, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
The price recorded in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $82.00 to $83.00, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
The price recorded in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $80.86 to $81.33, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.